Draft guideline on the clinical development of medicinal products for the treatment of Autism Spectrum Disorder

  • Email
  • Help

Document details

Download document Draft guideline on the clinical development of medicinal products for the treatment of Autism Spectrum Disorder
Reference number EMA/CHMP/598082/2013
Status draft: consultation closed
First published 2016-03-04
Last updated 2016-03-04

Summary

Autism Spectrum Disorder (ASD) is among the most common and varied disorders in paediatric psychiatry. It impacts significantly on social, occupational, or other important areas of functioning, and is a lifelong condition. Although various therapies and interventions are available, few are supported by scientific studies.